{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:57:42Z","timestamp":1789703862170,"version":"4.0.1"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T00:00:00Z","timestamp":1280448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bisphosphonate use has expanded beyond traditional applications to include treatment of a variety of low-bone-mass conditions. Complications associated with long-term bisphosphonate treatment have been noted, generating a critical need for information describing the local bisphosphonate-cell interactions responsible for these observations. This study demonstrates that a fluorescent bisphosphonate analogue, far-red fluorescent pamidronate (FRFP), is an accurate biomarker of bisphosphonate deposition and retention in vivo and can be used to monitor site-specific local drug concentration. In vitro, FRFP is competitively inhibited from the surface of homogenized rat cortical bone by traditional bisphosphonates. In vivo, FRFP delivery to the skeleton is rapid, with fluorescence linearly correlated with bone surface area. Limb fluorescence increases linearly with injected dose of FRFP; injected FRFP does not interfere with binding of standard bisphosphonates at the doses used in this study. Long-term FRFP retention studies demonstrated that FRFP fluorescence decreases in conditions of normal bone turnover, whereas fluorescence was retained in conditions of reduced bone turnover, demonstrating preservation of local FRFP concentration. In the mandible, FRFP localized to the alveolar bone and bone surrounding the periodontal ligament and molar roots, consistent with findings of osteonecrosis of the jaw. These findings support a role for FRFP as an effective in vivo marker for bisphosphonate site-specific deposition, turnover, and long-term retention in the skeleton. \u00a9 2010 American Society for Bone and Mineral Research<\/jats:p>","DOI":"10.1002\/jbmr.66","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T10:01:43Z","timestamp":1265623303000},"page":"1748-1758","source":"Crossref","is-referenced-by-count":75,"title":["Near-infrared fluorescent probe traces bisphosphonate delivery and retention in vivo"],"prefix":"10.1093","volume":"25","author":[{"given":"Kenneth M","family":"Kozloff","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA"},{"name":"Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo I","family":"Volakis","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA"},{"name":"Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C","family":"Marini","sequence":"additional","affiliation":[{"name":"Bone and Extracellular Matrix Branch, NICHD, NIH, Bethesda MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S","family":"Caird","sequence":"additional","affiliation":[{"name":"Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,7,30]]},"reference":[{"key":"2024020320112141000_bib1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science."},{"key":"2024020320112141000_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone."},{"key":"2024020320112141000_bib3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.5435\/00124635-200611000-00006","article-title":"Bisphosphonate use in children with bone disease","volume":"14","author":"Hickey","year":"2006","journal-title":"J Am Acad Orthop Surg."},{"key":"2024020320112141000_bib4","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2106\/JBJS.F.00964","article-title":"Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents","volume":"89","author":"Ramachandran","year":"2007","journal-title":"J Bone Joint Surg Am."},{"key":"2024020320112141000_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.bpo.0000150810.35794.e8","article-title":"Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series","volume":"25","author":"Sholas","year":"2005","journal-title":"J Pediatr Orthop."},{"key":"2024020320112141000_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N Engl J Med."},{"key":"2024020320112141000_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma."},{"key":"2024020320112141000_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00198-008-0725-9","article-title":"Spectroscopic markers of bone quality in alendronate-treated postmenopausal women","volume":"20","author":"Boskey","year":"2009","journal-title":"Osteoporos Int."},{"key":"2024020320112141000_bib9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1359\/jbmr.060701","article-title":"Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate","volume":"21","author":"Durchschlag","year":"2006","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate","volume":"19","author":"Munns","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-0722.2008.00529.x","article-title":"Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta","volume":"116","author":"Kamoun-Goldrat","year":"2008","journal-title":"Eur J Oral Sci."},{"key":"2024020320112141000_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00247-003-0865-1","article-title":"Radiographic features of bisphosphonate therapy in pediatric patients","volume":"33","author":"Grissom","year":"2003","journal-title":"Pediatr Radiol."},{"key":"2024020320112141000_bib13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1359\/JBMR.040303","article-title":"Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysis","volume":"19","author":"Rauch","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1148\/radiology.184.1.1609087","article-title":"Epi- and metaphyseal changes in children caused by administration of bisphosphonates","volume":"184","author":"van Persijn van Meerten","year":"1992","journal-title":"Radiology."},{"key":"2024020320112141000_bib15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","article-title":"Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta","volume":"40","author":"Rauch","year":"2007","journal-title":"Bone."},{"key":"2024020320112141000_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.081238","article-title":"Alendronate treatment of Brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but has detrimental effects on osteoblasts and bone formation and decreases predicted material properties","volume":"24","author":"Uveges","year":"2009","journal-title":"Journal of Bone and Mineral Research."},{"key":"2024020320112141000_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020320112141000_bib18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020320112141000_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","article-title":"Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis","volume":"42","author":"Rizzoli","year":"2008","journal-title":"Bone."},{"key":"2024020320112141000_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020320112141000_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","article-title":"Prolonged bisphosphonate release after treatment in children","volume":"356","author":"Papapoulos","year":"2007","journal-title":"N Engl J Med."},{"key":"2024020320112141000_bib23","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2106\/00004623-200707000-00015","article-title":"Zebra lines of pamidronate therapy in children","volume":"89","author":"Al Muderis","year":"2007","journal-title":"J Bone Joint Surg Am."},{"key":"2024020320112141000_bib24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.070504","article-title":"Non-invasive optical detection of bone mineral","volume":"22","author":"Kozloff","year":"2007","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib25","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nbt1201-1148","article-title":"In vivo near-infrared fluorescence imaging of osteoblastic activity","volume":"19","author":"Zaheer","year":"2001","journal-title":"Nat Biotechnol."},{"key":"2024020320112141000_bib26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jor.20518","article-title":"Fluorescence molecular tomography enables in vivo visualization and quantification of nonunion fracture repair induced by genetically engineered mesenchymal stem cells","volume":"26","author":"Zilberman","year":"2008","journal-title":"J Orthop Res."},{"key":"2024020320112141000_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1076-6332(03)00253-8","article-title":"Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer","volume":"10","author":"Lenkinski","year":"2003","journal-title":"Acad Radiol."},{"key":"2024020320112141000_bib28","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1161\/CIRCULATIONAHA.107.732867","article-title":"Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo","volume":"116","author":"Aikawa","year":"2007","journal-title":"Circulation."},{"key":"2024020320112141000_bib29","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.juro.2007.11.100","article-title":"A novel method of imaging calcium urolithiasis using fluorescence","volume":"179","author":"Figueiredo","year":"2008","journal-title":"J Urol."},{"key":"2024020320112141000_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bone.2007.12.225","article-title":"Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells","volume":"42","author":"Coxon","year":"2008","journal-title":"Bone."},{"key":"2024020320112141000_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm0103-123","article-title":"Shedding light onto live molecular targets","volume":"9","author":"Weissleder","year":"2003","journal-title":"Nat Med."},{"key":"2024020320112141000_bib32","doi-asserted-by":"crossref","first-page":"37923","DOI":"10.1074\/jbc.274.53.37923","article-title":"Use of the Cre\/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an a1(I) G349C substitution. Variability in phenotype in BrtlIV mice","volume":"274","author":"Forlino","year":"1999","journal-title":"J Biol Chem."},{"key":"2024020320112141000_bib33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1359\/JBMR.040111","article-title":"Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength","volume":"19","author":"Kozloff","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF02555853","article-title":"The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse","volume":"49","author":"Hoggarth","year":"1991","journal-title":"Calcif Tissue Int."},{"key":"2024020320112141000_bib35","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.165.3899.1262","article-title":"Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo","volume":"165","author":"Fleisch","year":"1969","journal-title":"Science."},{"key":"2024020320112141000_bib36","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1359\/jbmr.2003.18.11.2016","article-title":"Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats","volume":"18","author":"Little","year":"2003","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.blo.0000194728.62996.2d","article-title":"The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution","volume":"441","author":"Tanzer","year":"2005","journal-title":"Clin Orthop Relat Res."},{"key":"2024020320112141000_bib38","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.21824","article-title":"Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis","volume":"54","author":"Jarrett","year":"2006","journal-title":"Arthritis Rheum."},{"key":"2024020320112141000_bib39","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1359\/jbmr.080617","article-title":"Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo","volume":"23","author":"Plotkin","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib40","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J Clin Invest."},{"key":"2024020320112141000_bib41","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2006.05.006","article-title":"Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia","volume":"39","author":"Iwata","year":"2006","journal-title":"Bone."},{"key":"2024020320112141000_bib42","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1210\/en.2003-0717","article-title":"Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption","volume":"144","author":"Nakamura","year":"2003","journal-title":"Endocrinology."},{"key":"2024020320112141000_bib43","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384.013k07_384_392","article-title":"Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood."},{"key":"2024020320112141000_bib44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bone.2005.07.023","article-title":"Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy","volume":"38","author":"Leu","year":"2006","journal-title":"Bone."},{"key":"2024020320112141000_bib45","first-page":"1185","article-title":"Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed)","volume":"21","author":"Francis","year":"1980","journal-title":"J Nucl Med."},{"key":"2024020320112141000_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02547227","article-title":"The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals","volume":"11","author":"Jung","year":"1973","journal-title":"Calcif Tissue Res."},{"key":"2024020320112141000_bib47","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bone.2005.04.027","article-title":"Binding studies of [18F]-fluoride and polyphosphonates radiolabelled with [99mTc], [111In], [153Sm] and [188Re] on bone compartments: Verification of the pre vivo model?","volume":"37","author":"Mitterhauser","year":"2005","journal-title":"Bone."},{"key":"2024020320112141000_bib48","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/jbmr.5650091206","article-title":"Structural requirements for bisphosphonate actions in vitro","volume":"9","author":"van Beek","year":"1994","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone."},{"key":"2024020320112141000_bib50","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Invest."},{"key":"2024020320112141000_bib51","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1359\/JBMR.050522","article-title":"Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases","volume":"20","author":"Cremers","year":"2005","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone."},{"key":"2024020320112141000_bib53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0090-9556(25)08706-9","article-title":"Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats","volume":"20","author":"Lin","year":"1992","journal-title":"Drug Metab Dispos."},{"key":"2024020320112141000_bib54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib55","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/jc.2008-1122","article-title":"Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates","volume":"94","author":"Burnett-Bowie","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020320112141000_bib56","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1359\/jbmr.080804","article-title":"Cellular mechanism of decreased bone in Brtl mouse model of OI: Imbalance of decreased osteoblast function and increased osteoclasts and their precursors","volume":"23","author":"Uveges","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"(Suppl 5)","key":"2024020320112141000_bib57","first-page":"S16-20;","article-title":"Bone mineral crystal size","volume":"14","author":"Boskey","year":"2003","journal-title":"Osteoporos Int."},{"key":"2024020320112141000_bib58","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1359\/jbmr.090414","article-title":"Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture","volume":"24","author":"Gourion-Arsiquaud","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib59","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bone.2006.06.008","article-title":"Bone tissue compositional differences in women with and without osteoporotic fracture","volume":"39","author":"McCreadie","year":"2006","journal-title":"Bone."},{"key":"2024020320112141000_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrendo.2009.58","article-title":"Bone: Use of bisphosphonates in children-proceed with caution","volume":"5","author":"Marini","year":"2009","journal-title":"Nat Rev Endocrinol."},{"key":"2024020320112141000_bib61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib62","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","article-title":"Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"24","author":"Rauch","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib63","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet."},{"key":"2024020320112141000_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ncpendmet0075","article-title":"Should children with osteogenesis imperfecta be treated with bisphosphonates?","volume":"2","author":"Marini","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"2024020320112141000_bib65","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000151451","article-title":"Bisphosphonate-related osteonecrosis of the jaw: model and diagnosis with cone beam computerized tomography","volume":"189","author":"Barragan-Adjemian","year":"2009","journal-title":"Cells Tissues Organs."},{"key":"2024020320112141000_bib66","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1359\/jbmr.2000.15.10.2042","article-title":"Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats","volume":"15","author":"Li","year":"2000","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib67","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1359\/jbmr.081113","article-title":"Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing","volume":"24","author":"Gerstenfeld","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib68","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm729","article-title":"Fluorescence molecular tomography resolves protease activity in vivo","volume":"8","author":"Ntziachristos","year":"2002","journal-title":"Nat Med."},{"key":"2024020320112141000_bib69","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiol.2423052065","article-title":"Tomographic fluorescence imaging of tumor vascular volume in mice","volume":"242","author":"Montet","year":"2007","journal-title":"Radiology."},{"key":"2024020320112141000_bib70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1162\/153535002320162732","article-title":"In vivo tomographic imaging of near-infrared fluorescent probes","volume":"1","author":"Ntziachristos","year":"2002","journal-title":"Mol Imaging."},{"key":"2024020320112141000_bib71","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2008.10.036","article-title":"Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo","volume":"44","author":"Kozloff","year":"2009","journal-title":"Bone."},{"key":"2024020320112141000_bib72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1359\/jbmr.2002.17.1.15","article-title":"Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage","volume":"17","author":"Kalajzic","year":"2002","journal-title":"J Bone Miner Res."},{"key":"2024020320112141000_bib73","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000151745","article-title":"Time lapse imaging techniques for comparison of mineralization dynamics in primary murine osteoblasts and the late osteoblast\/early osteocyte-like cell line MLO-A5","volume":"189","author":"Dallas","year":"2009","journal-title":"Cells Tissues Organs."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.66","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/25\/8\/1748\/7600064","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/25\/8\/1748\/7600064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T21:06:40Z","timestamp":1739826400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/25\/8\/1748-1758\/7600064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,30]]},"references-count":73,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,7,30]]},"published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.66","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,8,1]]},"published":{"date-parts":[[2010,7,30]]}}}